Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Hims & Hers

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Hims & Hers head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 27 · Grade B

Hims & Hers

Visit Hims & Hers Full brief →

FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 85 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Hims & Hers a bad call — it's best for readers who want app-based access to branded medication and understand the separate recurring care fee. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
83
Supply Reliability
95
86
Transparency
90
83
Access Breadth
93
88
Clinical Oversight
92
86
Track Record
88
86
CoreAge RxBrief Score 94 · 85Hims & Hers

Price, coverage & the tracker

CoreAge RxHims & Hers
Brief Score94/100 (A)85/100 (B)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Wegovy from $149/mo + membership

Pill from $149/mo; pen from $199/mo.

Membership: $39 first month, then $149/mo.

Full price details

Wegovy pill from $149/mo or pen from $199/mo, plus membership $39 first month then $149/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Zepbound from $299/mo + membership

Vial or KwikPen starting price.

Membership: $39 first month, then $149/mo.

Full price details

Zepbound vial or KwikPen from $299/mo, plus membership $39 first month then $149/mo

CoverageUS only; restrictions by state, confirmed at intakeNot available in all 50 states; confirm location and treatment eligibility
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Hims & Hers: Hims now advertises branded GLP-1 options with a separate weight-loss membership. Compare the recurring membership charge as well as the medication price.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.